PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,210 | -85.5% | 15,289 | -80.5% | 0.01% | -86.0% |
| Q2 2023 | $276,929 | +9.8% | 78,450 | -3.9% | 0.05% | -5.7% |
| Q1 2023 | $252,203 | -36.8% | 81,619 | -13.5% | 0.05% | -37.6% |
| Q4 2022 | $399,122 | +504.7% | 94,355 | +236.3% | 0.08% | +431.2% |
| Q3 2022 | $66,000 | -35.9% | 28,056 | -22.3% | 0.02% | -61.9% |
| Q2 2022 | $103,000 | -41.5% | 36,130 | -41.0% | 0.04% | -45.5% |
| Q1 2022 | $176,000 | +91.3% | 61,218 | +102.0% | 0.08% | +48.1% |
| Q4 2021 | $92,000 | -36.1% | 30,308 | +93.0% | 0.05% | +6.1% |
| Q2 2021 | $144,000 | – | 15,705 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |